Eos Biotechnology
Latest round
- Series A
Last raised
- Jul 1997
Total raised
- $9.5M
Investors
- 5
About Eos Biotechnology
Eos Biotechnology, Inc. is a functional genomics company developing therapeutic antibodies for cancer, angiogenesis, and inflammation.
Who invested in Eos Biotechnology
5 investors across 1 round
See all investors in Eos Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 1, 1997
Amount
$9.5M
Investors
Questions about Eos Biotechnology
Who invested in Eos Biotechnology?
Eos Biotechnology has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eos Biotechnology raised?
Eos Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eos Biotechnology last raise money?
Eos Biotechnology's most recent round on record is a Series A, in Jul 1997.
What does Eos Biotechnology do?
Eos Biotechnology is a biotechnology company.
Where is Eos Biotechnology headquartered?
Eos Biotechnology is headquartered in San Francisco, US.
Which VCs invest in companies like Eos Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eos Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Eos Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.